ATARA BIOTHERAPEUTICS, INC. Lease Obligation Incurred
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Lease Obligation Incurred of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2021-03-01
- ATARA BIOTHERAPEUTICS, INC. lease obligation incurred for the quarter ending 2019-12-31 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. lease obligation incurred for the quarter ending 2019-09-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. lease obligation incurred for the quarter ending 2019-06-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. lease obligation incurred for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. lease obligation incurred for fiscal 2020 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. lease obligation incurred for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- ATARA BIOTHERAPEUTICS, INC. lease obligation incurred for fiscal 2018 was $441.00K, a 95.55% decline from fiscal 2017.
- ATARA BIOTHERAPEUTICS, INC. lease obligation incurred for fiscal 2017 was $9.90M.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $441.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $441.00K 10-Q · filed 2019-11-07 | $4.13M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $441.00K 10-Q · filed 2019-08-08 | $4.13M derived: sum of 3 quarters · filed 2020-02-27 | -$525.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $441.00K 10-Q · filed 2019-05-09 | $4.13M derived: sum of 2 quarters · filed 2020-02-27 | -$525.00K derived: sum of 3 quarters · filed 2020-02-27 | $10.06M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$966.00K derived: sum of 2 quarters · filed 2020-02-27 | $9.62M derived: sum of 3 quarters · filed 2020-02-27 | $9.90M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$4.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $5.93M derived: sum of 2 quarters · filed 2017-11-09 | $6.21M 10-Q · filed 2017-11-09 | $6.21M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | $10.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $10.87M 10-Q · filed 2017-08-07 | $10.87M derived: sum of 3 quarters · filed 2018-05-08 | $10.87M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | $286.00K 10-Q · filed 2018-05-08 | $286.00K derived: sum of 2 quarters · filed 2018-05-08 | $286.00K derived: sum of 3 quarters · filed 2018-05-08 | $286.00K derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $0.00 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |